DE LAURENTIIS, MICHELINO
 Distribuzione geografica
Continente #
EU - Europa 617
AS - Asia 397
NA - Nord America 180
AF - Africa 40
SA - Sud America 11
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 1.259
Nazione #
DE - Germania 237
US - Stati Uniti d'America 164
IT - Italia 152
CN - Cina 99
VN - Vietnam 80
JP - Giappone 79
IE - Irlanda 51
IN - India 45
GB - Regno Unito 42
EE - Estonia 27
ID - Indonesia 27
EG - Egitto 22
FR - Francia 17
RU - Federazione Russa 17
NL - Olanda 12
TW - Taiwan 12
UA - Ucraina 12
KR - Corea 11
IR - Iran 9
BR - Brasile 8
CA - Canada 8
RO - Romania 8
CI - Costa d'Avorio 7
PL - Polonia 6
TH - Thailandia 6
AP - ???statistics.table.value.countryCode.AP??? 5
AU - Australia 5
CZ - Repubblica Ceca 5
ES - Italia 5
PA - Panama 5
HK - Hong Kong 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PH - Filippine 4
TR - Turchia 4
ET - Etiopia 3
GR - Grecia 3
MA - Marocco 3
PK - Pakistan 3
SA - Arabia Saudita 3
SE - Svezia 3
TN - Tunisia 3
AT - Austria 2
BD - Bangladesh 2
BG - Bulgaria 2
CH - Svizzera 2
IQ - Iraq 2
ME - Montenegro 2
MX - Messico 2
NG - Nigeria 2
NO - Norvegia 2
PE - Perù 2
PT - Portogallo 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
BE - Belgio 1
FI - Finlandia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
LB - Libano 1
LV - Lettonia 1
RS - Serbia 1
SG - Singapore 1
SI - Slovenia 1
Totale 1.259
Città #
Dong Ket 47
Dublin 36
Nürnberg 30
Beijing 27
University Park 20
Tokyo 18
Hanoi 17
Jakarta 14
Wilmington 14
Houston 12
Wuhan 12
Berkley 11
Napoli 11
Shanghai 11
Milan 9
Taipei 9
Ashburn 8
Hangzhou 8
Leawood 8
Mountain View 7
Ann Arbor 6
Boardman 5
Pueblo Nuevo 5
Rome 5
Woodbridge 5
Bangalore 4
Bologna 4
Dearborn 4
Demak 4
Palermo 4
Seoul 4
Tabriz 4
Amsterdam 3
Bangkok 3
Bengaluru 3
Caivano 3
Carugate 3
Changsha 3
Chengdu 3
Chennai 3
Gurgaon 3
High Wycombe 3
Kyiv 3
Marseille 3
Montréal 3
Multan 3
New York 3
Seattle 3
Shibuya 3
Tallinn 3
Tettnang 3
Tokorozawa 3
Torbay 3
Torino 3
Wenzhou 3
Block 2
Buffalo 2
Central District 2
Chatsworth 2
Comazzo 2
Delhi 2
Duncan 2
Epsom 2
Genoa 2
Genova 2
Goran 2
Hyderabad 2
Invercargill 2
Lagos 2
Landshut 2
Lecce 2
Lima 2
London 2
Manado 2
Mellingen 2
Misr 2
Moscow 2
Munich 2
Nanjing 2
New Delhi 2
Newbury Park 2
Nobitome 2
Ocala 2
Omegna 2
Pallikunnu 2
Petaling Jaya 2
Plainview 2
Portici 2
Prato 2
Rochester 2
Saga 2
Salvador 2
San Genesio Ed Uniti 2
San Jose 2
Sapporo 2
Shenyang 2
Stockholm 2
Toronto 2
Toulouse 2
Turin 2
Totale 542
Nome #
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: An open-label, 2 × 2 factorial, randomised phase 3 trial, file e268a72d-2d66-4c8f-e053-1705fe0a812c 478
Endocrine therapy in post-menopausal women with metastatic breast cancer: From literature and guidelines to clinical practice, file e268a72e-63f2-4c8f-e053-1705fe0a812c 278
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial, file e268a72e-636c-4c8f-e053-1705fe0a812c 198
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy, file e268a72d-09b5-4c8f-e053-1705fe0a812c 71
Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study, file e268a72d-09b3-4c8f-e053-1705fe0a812c 40
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer, file e268a72e-5ba7-4c8f-e053-1705fe0a812c 31
Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial, file e268a72e-6328-4c8f-e053-1705fe0a812c 30
Combined effect of obesity and diabetes on early breast cancer outcome: A prospective observational study, file e268a72f-b2fb-4c8f-e053-1705fe0a812c 27
Body mass index and treatment outcomes following neoadjuvant therapy in women aged 45 y or younger: Evidence from a historic cohort, file e268a72e-5bbf-4c8f-e053-1705fe0a812c 22
Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients, file e268a72e-635c-4c8f-e053-1705fe0a812c 17
Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy., file e268a72d-1a21-4c8f-e053-1705fe0a812c 12
Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer, file e268a72e-548a-4c8f-e053-1705fe0a812c 12
The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014, file e268a72e-57f5-4c8f-e053-1705fe0a812c 12
The role of taxanes in triple-negative breast cancer: literature review, file e268a72e-636e-4c8f-e053-1705fe0a812c 11
The hydrophilic extract from a new tomato genotype (named DHO) kills cancer cell lines through the modulation of the DNA damage response induced by Campthotecin treatment, file ffd6e718-a96c-40bc-9abc-b8e6e757575f 9
Triple-Negative Breast Cancer comparison with Canine Mammary Tumors from light microscopy to molecular pathology, file e268a733-041e-4c8f-e053-1705fe0a812c 8
Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series, file e268a72e-5488-4c8f-e053-1705fe0a812c 6
Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype, file e268a72e-57bd-4c8f-e053-1705fe0a812c 6
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI), file e268a732-bbae-4c8f-e053-1705fe0a812c 5
Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives, file e268a72e-53c2-4c8f-e053-1705fe0a812c 4
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials, file e268a72e-5587-4c8f-e053-1705fe0a812c 4
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials, file e268a72e-548e-4c8f-e053-1705fe0a812c 3
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials, file e268a72e-5dc8-4c8f-e053-1705fe0a812c 3
Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial, file e268a72e-6370-4c8f-e053-1705fe0a812c 3
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial, file e268a732-95c4-4c8f-e053-1705fe0a812c 3
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial, file e268a732-a40f-4c8f-e053-1705fe0a812c 3
Dendritic cell-based vaccines: clinical applications in breast cancer, file a1d99c59-9f26-418e-be64-205219a492ac 2
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial, file e268a732-bee7-4c8f-e053-1705fe0a812c 2
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis, file e268a732-7d61-4c8f-e053-1705fe0a812c 1
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial, file e268a732-995c-4c8f-e053-1705fe0a812c 1
Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do?, file e268a732-dcd3-4c8f-e053-1705fe0a812c 1
Totale 1.303
Categoria #
all - tutte 2.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.339


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201960 0 0 0 0 0 0 0 0 0 15 24 21
2019/2020167 18 21 15 5 7 20 14 15 8 18 17 9
2020/2021222 10 16 19 19 28 12 42 10 12 15 8 31
2021/2022147 38 3 9 14 5 8 10 12 19 7 10 12
2022/2023107 12 8 2 18 15 7 5 6 4 8 20 2
2023/2024104 3 7 14 20 10 7 3 20 3 17 0 0
Totale 1.303